Treatment with Moxifloxacin-containing Antibiotic Regimen for Mycobacterium Avium Complex Lung Disease

분야: 의약학 > 내과학
저자: ( Gooh Yeon Hong ) , ( Byeong Ho Jeong ) , ( Hye Yun Park ) , ( Kyeongman Jeon ) , ( O Jung Kwon ) , ( Seung Heon Lee ) , ( Chang Ki Kim ) , ( Sung Jae Shin ) , ( Won Jung Koh )
발행기관: 대한결핵 및 호흡기학회
간행물정보: 대한결핵및호흡기학회 추계학술발표초록집 2012년, 제114권 163(총1페이지)
파일형식: 0y909834.pdf [무료 PDF 뷰어 다운로드]
※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
구매가격: 1,000원
적립금: 30원 (구매자료 3% 적립)

연관 논문

Free Paper Presentation : OS-34 ; Intermittent Antibiotic Therapy for the Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease

The Korean Academy of Tuberculosis and Respiratory Diseases : Slide Session ; OS-034 : Mycobacterial Diseases ; Intermittent Antibiotic Therapy for the Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease

REVIEW : Respiratory Review of 2014: Tuberculosis and Nontuberculous Mycobacterial Pulmonary Disease

F-21 Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease

F-20 Treatment Outcomes of Mycobacterium avium Complex Lung Disease

영문초록

Objectives: To evaluate the clinical efficacy of a Moxifloxacin (MXF)-containing regimen for the treatment of Mycobacterium avium complex (MAC) lung disease. Patients and Methods: Consecutive patients with MAC lung disease who were diagnosed between January 2002 and December 2011 were identified using the database of the NTM Registry of Samsung Medical Center. We identified 47 patients (32 males and 15 females; median age, 65 yr [IQR 56-70 yr]) who received MXF for ≥4 weeks for the treatment of MAC lung disease. Results: Thirty-two patients (68%) were treated with MXF-containing regimens because of persistent positive culture after at least 6 months of clarithromycin (CLR)-based standardized antibiotic therapy and 15 patients (32%) received MXF as a substitute for ethambutol (EMB) because they discontinued EMB due to side effect such as optic neuritis. The sputum conversion rate after MXF therapy was 34% (11/32) and 27% (4/15), respectively. The overall treatment success rate was 32% (15/47) and sputum culture conversion failed in 32 patients (68%). A positive sputum AFB smear at the start of treatment with MXF containing-regimens was an independent predictor of an unfavorable microbiologic response. Conclusions: MXF-containing antibiotic treatment for MAC lung disease can be effective in some cases. Further research is needed to study the clinical efficacy of a MXF-containing regimen for the treatment of MAC lung disease.

추천자료

HIV Disease-AIDS & related disorder

[자연] 구강질환에 대해서

의학용어 약어정리

[PBL] 전신부종과 호흡곤란을 호소한 젊은 여자

약물 전달 시스템에서 주요 연구 분야에 대한 특허 분석

[발생공학] 배아 줄기 세포 연구(영문)

[[솔루션]] :: Lehninger Biochemistry 5edition[the foundations of Biochemistry]

[자연] 설사와 변비

[자연] 호흡기계 병력과 이학적 검사

[임상화학] Mycobacterium culture

오늘 본 자료